News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Nov 7, 2018 Corporate and finance Novavax Reports Third Quarter 2018 Financial Results Download Nov 1, 2018 Corporate and finance Novavax Appoints Rachel King to Board of Directors Download Nov 1, 2018 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018 Download Oct 2, 2018 RSV Novavax to Highlight RSV Program Data at Two Upcoming Meetings Download Sep 26, 2018 Corporate and finance Novavax to Present at Two Upcoming Investor Conferences Download Sep 25, 2018 Seasonal influenza Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults Download Aug 28, 2018 Corporate and finance Novavax to Participate at Two Upcoming Investor Conferences Download Aug 8, 2018 Corporate and finance Novavax Reports Second Quarter 2018 Financial Results Download Aug 1, 2018 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018 Download Jun 13, 2018 Seasonal influenza New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data Download Show 5102550100 per page«1…23242526272829…37»